A phase 1 clinical trial evaluating marizomib, pomalidomide and low‐dose dexamethasone in relapsed and refractory multiple myeloma (NPI‐0052‐107): final study results von Spencer, Andrew, Harrison, Simon, Zonder, Jeffrey, Badros, Ashraf, Laubach, Jacob, Bergin, Krystal, Khot, Amit, Zimmerman, Todd, Chauhan, Dharminder, Levin, Nancy, MacLaren, Ann, Reich, Steven D., Trikha, Mohit, Richardson, Paul

Volltext

Phase I Clinical Trial of Marizomib (NPI-0052) in Patients with Advanced Malignancies Including Multiple Myeloma: Study NPI-0052-102 Final Results von Harrison, Simon J, Mainwaring, Paul, Price, Timothy, Millward, Michael J, Padrik, Peeter, Underhill, Craig R, Cannell, Paul K, Reich, Steven D, Trikha, Mohit, Spencer, Andrew

Volltext

Phase I Trial of the Oral Antiangiogenesis Agent AG-013736 in Patients With Advanced Solid Tumors: Pharmacokinetic and Clinical Results von RUGO, Hope S, HERBST, Roy S, LIU, Glenn, PARK, John W, KIES, Merrill S, STEINFELDT, Heidi M, PITHAVALA, Yazdi K, REICH, Steven D, FREDDO, James L, WILDING, George

Volltext

The Great Black Migration: A Historical Encyclopedia of the American Mosaic von Reich, Steven A

Volltext

Marizomib irreversibly inhibits proteasome to overcome compensatory hyperactivation in multiple myeloma and solid tumour patients von Levin, Nancy, Spencer, Andrew, Harrison, Simon J., Chauhan, Dharminder, Burrows, Francis J., Anderson, Kenneth C., Reich, Steven D., Richardson, Paul G., Trikha, Mohit

Volltext

First-in-human trial of an anti-5T4 antibody-monomethylauristatin conjugate, PF-06263507, in patients with advanced solid tumors von Shapiro, Geoffrey I., Vaishampayan, Ulka N., LoRusso, Patricia, Barton, Jeremy, Hua, Steven, Reich, Steven D., Shazer, Ronald, Taylor, Carrie T., Xuan, Dawei, Borghaei, Hossein

Volltext

A randomized phase 1 pharmacokinetic trial comparing the potential biosimilar PF‐05280014 with trastuzumab in healthy volunteers (REFLECTIONS B327‐01) von Yin, Donghua, Barker, Kerry B., Li, Ruifeng, Meng, Xu, Reich, Steven D., Ricart, Alejandro D., Rudin, Dan, Taylor, Carrie T., Zacharchuk, Charles M., Hansson, Arne G.

Volltext

Dynamic Contrast-Enhanced Magnetic Resonance Imaging As a Pharmacodynamic Measure of Response After Acute Dosing of AG-013736, an Oral Angiogenesis Inhibitor, in Patients With Adva... von LIU, Glenn, RUGO, Hope S, CHARNSANGAVEJ, Chusilp, PARK, John W, ASHTON, Edward A, STEINFELDT, Heidi M, PITHAVALA, Yazdi K, REICH, Steven D, HERBST, Roy S, WILDING, George, MCSHANE, Teresa M, EVELHOCH, Jeffrey L, NG, Chaan, JACKSON, Edward, KELCZ, Frederick, YEH, Benjamin M, LEE, Fred T

Volltext

Marizomib alone or in combination with bevacizumab in patients with recurrent glioblastoma: Phase I/II clinical trial data von Bota, Daniela A, Mason, Warren, Kesari, Santosh, Magge, Rajiv, Winograd, Benjamin, Elias, Ileana, Reich, Steven D, Levin, Nancy, Trikha, Mohit, Desjardins, Annick

Volltext

A non-comparative randomized phase II study of 2 doses of ATN-224, a copper/zinc superoxide dismutase inhibitor, in patients with biochemically recurrent hormone-naïve prostate can... von Lin, Jianqing, M.D, Zahurak, Marianna, M.S, Beer, Tomasz M., M.D, Ryan, Charles J., M.D, Wilding, George, M.D, Mathew, Paul, M.D, Morris, Michael, M.D, Callahan, Jennifer A., M.A.S, Gordon, Gilad, M.D, Reich, Steven D., M.D, Carducci, Michael A., M.D, Antonarakis, Emmanuel S., M.D

Volltext

Phase 1 First-in-Human Trial of the Vascular Disrupting Agent Plinabulin (NPI-2358) in Patients with Solid Tumors or Lymphomas von MITA, Monica M, SPEAR, Matthew A, PILAT, Maryjo, LLOYD, G. Kenneth, NEUTEBOOM, Saskia T. C, CROPP, Gillian, ASHTON, Edward, LORUSSO, Patricia M, YEE, Lorrin K, MITA, Alain C, HEATH, Elisabeth I, PAPADOPOULOS, Kyriakos P, FEDERICO, Kristine C, REICH, Steven D, ROMERO, Ofelia, MALBURG, Lisa

Volltext

Phase I Study of Copper-Binding Agent ATN-224 in Patients with Advanced Solid Tumors von LOWNDES, Sarah A, ADAMS, Avril, MIDDLETON, Mark, MAZAR, Andrew, HARRIS, Adrian L, TIMMS, Anthony, FISHER, Nita, SMYTHE, Jon, WATT, Suzanne M, JOEL, Simon, DONATE, Fernando, HAYWARD, Carolyn, REICH, Steven

Volltext

A case of myelopathy because of enchondromas from Maffucci syndrome with successful surgical treatment von McCarthy, Christopher M., MD, Blecher, Haim, MD, Reich, Steven, MD

Volltext

Topical bexarotene therapy for patients with refractory or persistent early-stage cutaneous T-cell lymphoma: results of the phase III clinical trial von Heald, Peter, Mehlmauer, Marilyn, Martin, Ann G, Crowley, Constance A, Yocum, Richard C, Reich, Steven D

Volltext

Lumbar hemangioma masking a plasma cell tumor—case report and review of the literature von Haque, Maahir U., MD, Wilson, Adam N., MD, Blecher, Haim D., MD, Reich, Steven M., MD

Volltext

Evaluating imbalances of adverse events during biosimilar development von Vana, Alicia M., Freyman, Amy W., Reich, Steven D., Yin, Donghua, Li, Ruifeng, Anderson, Scott, Jacobs, Ira A., Zacharchuk, Charles M., Ewesuedo, Reginald

Volltext

Multi-Institutional Phase I/II Trial of Oral Bexarotene in Combination With Cisplatin and Vinorelbine in Previously Untreated Patients With Advanced Non–Small-Cell Lung Cancer von KHURI, Fadlo R, RIGAS, James R, HONG, Waun K, FIGLIN, Robert A, GRALLA, Richard J, SHIN, Dong M, MUNDEN, Reginald, FOX, Nikolaus, MI RA HUYGHE, YIN KEAN, REICH, Steven D

Volltext

Splenic artery embolization: a single center experience on the safety, efficacy, and clinical outcomes von Gaba, Ron C, Katz, Jeremy R, Parvinian, Ahmad, Reich, Steven, Omene, Benedictta O, Yap, Felix Y, Owens, Charles A, Knuttinen, M Grace, Bui, James T

Volltext

The Great Migration and the Literary Imagination von Reich, Steven A.

Volltext

The anti-angiogenesis agent, AG-013736, has minimal activity in elderly patients with poor prognosis acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) von Giles, Francis J., Bellamy, William T., Estrov, Zeev, O’Brien, Susan M., Verstovsek, Srdan, Ravandi, Farhad, Beran, Miloslav, Bycott, Paul, Pithavala, Yazdi, Steinfeldt, Heidi, Reich, Steven D., List, Alan F., Yee, Karen W.L.

Volltext